Western CDMOs say in close proximity to-term stewardship on the pharmaceutical source chain is likely to demand them to repurpose output lines to manufacture drugs and raw materials crucial to battling the new coronavirus.="" in="" accordance="" with="" the="" regulatory="" overall flexibility="" act,="" fda="" has="" regarded="" the="" result="" o